Advertisement
Screener

ENDRA LIFE SCIENCES INC. (NDRA) Revenue

ENDRA LIFE SCIENCES INC. Revenue

ENDRA LIFE SCIENCES INC. (NDRA) reported Revenue of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.

Discontinued › Income Statement › Revenue

us-gaap:Revenues · last filed 2021-03-25

  • ENDRA LIFE SCIENCES INC. revenues for the quarter ending 2019-12-31 was $0.00.
  • ENDRA LIFE SCIENCES INC. revenues for the quarter ending 2019-09-30 was $0.00.
  • ENDRA LIFE SCIENCES INC. revenues for the quarter ending 2019-06-30 was $0.00.
  • ENDRA LIFE SCIENCES INC. revenues for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
  • ENDRA LIFE SCIENCES INC. revenues for fiscal 2020 was $0.00.
  • ENDRA LIFE SCIENCES INC. revenues for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
  • ENDRA LIFE SCIENCES INC. revenues for fiscal 2018 was $6.17K, a 98.24% decline from fiscal 2017.
  • ENDRA LIFE SCIENCES INC. revenues for fiscal 2017 was $351.62K.
Period endRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 12 month
2020-12-31$0.00
10-K · filed 2021-03-25
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
$0.00
derived: sum of 2 quarters · filed 2021-03-25
$0.00
derived: sum of 3 quarters · filed 2021-03-25
$0.00
10-K · filed 2021-03-25
2019-09-30$0.00
10-Q · filed 2019-11-13
$0.00
derived: sum of 2 quarters · filed 2019-11-13
$0.00
10-Q · filed 2019-11-13
$0.00
derived: sum of 4 quarters · filed 2020-03-26
2019-06-30$0.00
10-Q · filed 2019-08-08
$0.00
10-Q · filed 2019-08-08
$0.00
derived: sum of 3 quarters · filed 2020-03-26
$0.00
derived: sum of 4 quarters · filed 2020-03-26
2019-03-31$0.00
10-Q · filed 2019-05-14
$0.00
derived: sum of 2 quarters · filed 2020-03-26
$0.00
derived: sum of 3 quarters · filed 2020-03-26
$0.00
derived: sum of 4 quarters · filed 2020-03-26
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
$0.00
derived: sum of 2 quarters · filed 2020-03-26
$0.00
derived: sum of 3 quarters · filed 2020-03-26
$6.17K
10-K · filed 2020-03-26
2018-09-30$0.00
10-Q · filed 2019-11-13
$0.00
derived: sum of 2 quarters · filed 2019-11-13
$6.17K
10-Q · filed 2019-11-13
$13.02K
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30$0.00
10-Q · filed 2019-08-08
$6.17K
10-Q · filed 2019-08-08
$13.02K
derived: sum of 3 quarters · filed 2019-08-08
$300.02K
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$6.17K
10-Q · filed 2019-05-14
$13.02K
derived: sum of 2 quarters · filed 2019-05-14
$300.02K
derived: sum of 3 quarters · filed 2019-05-14
$357.80K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$6.85K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11
$293.85K
derived: sum of 2 quarters · filed 2019-03-11
$351.62K
derived: sum of 3 quarters · filed 2019-03-11
$351.62K
10-K · filed 2019-03-11
2017-09-30$287.00K
10-Q · filed 2018-11-05
$344.77K
derived: sum of 2 quarters · filed 2018-11-05
$344.77K
10-Q · filed 2018-11-05
2017-06-30$57.77K
10-Q · filed 2018-08-13
$57.77K
10-Q · filed 2018-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRIDEX CORP (IRIX)United States$0.011B
Nuwellis, Inc. (NUWE)United States$0.003B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B